Autodesk (NASDAQ:ADSK) is now covered by analysts at Wells Fargo & Company. They set an âoverweightâ rating and a $340.00 price target on the stock. This represents a 18.5% upside from the current price of $286.93. |
Agios Pharmaceuticals (NASDAQ:AGIO) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating and a $51.00 price target on the stock. This represents a 19.3% upside from the current price of $42.74. |
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating on the stock.The current price is $295.73. |
Apellis Pharmaceuticals (NASDAQ:APLS) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating on the stock.The current price is $27.50. |
Apellis Pharmaceuticals (NASDAQ:APLS) is now covered by analysts at William Blair. They set an âoutperformâ rating on the stock.The current price is $27.50. |
Antero Resources (NYSE:AR) is now covered by analysts at UBS Group AG. They set a âneutralâ rating and a $33.00 price target on the stock. This represents a 20.6% upside from the current price of $27.37. |
Asure Software (NASDAQ:ASUR) is now covered by analysts at Stephens. They set an âoverweightâ rating and a $13.00 price target on the stock. This represents a 43.3% upside from the current price of $9.07. |
BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating and a $44.00 price target on the stock. This represents a 68.2% upside from the current price of $26.16. |
Beam Therapeutics (NASDAQ:BEAM) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating and a $24.00 price target on the stock. This represents a 12.2% downside from the current price of $27.33. |
Burke & Herbert Financial Services (NASDAQ:BHRB) is now covered by analysts at DA Davidson. They set a âbuyâ rating and a $76.00 price target on the stock. This represents a 19.9% upside from the current price of $63.41. |
Brookdale Senior Living (NYSE:BKD) is now covered by analysts at Jefferies Financial Group Inc.. They set a âbuyâ rating and a $8.00 price target on the stock. This represents a 18.7% upside from the current price of $6.74. |
Benitec Biopharma (NASDAQ:BNTC) is now covered by analysts at Oppenheimer Holdings Inc.. They set an âoutperformâ rating and a $35.00 price target on the stock. This represents a 240.1% upside from the current price of $10.29. |
Maplebear (NASDAQ:CART) is now covered by analysts at Jefferies Financial Group Inc.. They set a âholdâ rating and a $43.00 price target on the stock. This represents a 2.7% upside from the current price of $41.85. |
Chord Energy (NASDAQ:CHRD) is now covered by analysts at UBS Group AG. They set a âbuyâ rating and a $168.00 price target on the stock. This represents a 31.2% upside from the current price of $128.07. |
Civitas Resources (NYSE:CIVI) is now covered by analysts at UBS Group AG. They set a âneutralâ rating and a $60.00 price target on the stock. This represents a 19.5% upside from the current price of $50.23. |
California Resources (NYSE:CRC) is now covered by analysts at UBS Group AG. They set a âbuyâ rating and a $68.00 price target on the stock. This represents a 29.2% upside from the current price of $52.64. |
Walt Disney (NYSE:DIS) is now covered by analysts at Piper Sandler. They set a âneutralâ rating and a $95.00 price target on the stock. This represents a 0.7% downside from the current price of $95.67. |
EyePoint Pharmaceuticals (NASDAQ:EYPT) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating on the stock.The current price is $10.65. |
Freshworks (NASDAQ:FRSH) is now covered by analysts at Wells Fargo & Company. They set an âequal weightâ rating and a $11.00 price target on the stock. This represents a 2.5% downside from the current price of $11.28. |
Geron (NASDAQ:GERN) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating and a $6.00 price target on the stock. This represents a 44.2% upside from the current price of $4.16. |
Disc Medicine (NASDAQ:IRON) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating on the stock.The current price is $47.96. |
Keros Therapeutics (NASDAQ:KROS) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating on the stock.The current price is $61.01. |
Klaviyo (NYSE:KVYO) is now covered by analysts at Wells Fargo & Company. They set an âequal weightâ rating and a $37.00 price target on the stock. This represents a 1.2% upside from the current price of $36.57. |
Liquidia (NASDAQ:LQDA) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating and a $30.00 price target on the stock. This represents a 161.3% upside from the current price of $11.48. |
Larimar Therapeutics (NASDAQ:LRMR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an âoutperformâ rating and a $26.00 price target on the stock. This represents a 232.5% upside from the current price of $7.82. |
Ocular Therapeutix (NASDAQ:OCUL) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating and a $22.00 price target on the stock. This represents a 102.0% upside from the current price of $10.89. |
Paycor HCM (NASDAQ:PYCR) is now covered by analysts at Stephens. They set an âoverweightâ rating and a $18.00 price target on the stock. This represents a 29.4% upside from the current price of $13.91. |
Qualys (NASDAQ:QLYS) is now covered by analysts at Jefferies Financial Group Inc.. They set a âholdâ rating and a $135.00 price target on the stock. This represents a 6.7% upside from the current price of $126.51. |
Rocket Pharmaceuticals (NASDAQ:RCKT) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating and a $50.00 price target on the stock. This represents a 185.7% upside from the current price of $17.50. |
RLI (NYSE:RLI) is now covered by analysts at Oppenheimer Holdings Inc.. They set a âmarket performâ rating on the stock.The current price is $161.26. |
Rapid7 (NASDAQ:RPD) is now covered by analysts at Jefferies Financial Group Inc.. They set a âbuyâ rating and a $50.00 price target on the stock. This represents a 23.9% upside from the current price of $40.34. |
Scilex (NASDAQ:SCLX) is now covered by analysts at Alliance Global Partners. They set a âbuyâ rating and a $14.00 price target on the stock. This represents a 1345.2% upside from the current price of $0.97. |
Tenable (NASDAQ:TENB) is now covered by analysts at Jefferies Financial Group Inc.. They set a âholdâ rating and a $45.00 price target on the stock. This represents a 6.4% upside from the current price of $42.31. |
Travere Therapeutics (NASDAQ:TVTX) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating on the stock.The current price is $18.01. |
Veracyte (NASDAQ:VCYT) is now covered by analysts at UBS Group AG. They set a âbuyâ rating and a $43.00 price target on the stock. This represents a 23.5% upside from the current price of $34.81. |
Vera Therapeutics (NASDAQ:VERA) is now covered by analysts at Scotiabank. They set a âsector outperformâ rating on the stock.The current price is $40.77. |
Vertex Pharmaceuticals (NASDAQ:VRTX) is now covered by analysts at Scotiabank. They set a âsector performâ rating on the stock.The current price is $484.77. |
Voyager Therapeutics (NASDAQ:VYGR) is now covered by analysts at Leerink Partners. They set an âoutperformâ rating and a $15.00 price target on the stock. This represents a 96.1% upside from the current price of $7.65. |